Orchidectomy alone for stage I seminoma of the testis
Open Access
- 1 March 1990
- Vol. 65 (5) , 1115-1118
- https://doi.org/10.1002/1097-0142(19900301)65:5<1115::aid-cncr2820650513>3.0.co;2-6
Abstract
Between 1983 and 1988, 113 patients with Stage I seminoma were managed after orchidectomy by surveillance rather than adjuvant radiotherapy. The actuarial risk of relapse at 3 years was 15.8% (95% confidence interval, 7.8% to 23.8%). All 13 patients who experienced a relapse are currently in remission (4 to 45 months after salvage therapy), although 5 suffered second relapses requiring further treatment. Close surveillance is a safe alternative to adjuvant radiotherapy in Stage I seminoma. However, the policy requires prolonged observation of patients with intensive use of resources. Therefore, adjuvant radiotherapy should be considered the treatment of choice.This publication has 7 references indexed in Scilit:
- Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- Radiotherapy for Stage I seminoma testis: Results of treatment and complicationsRadiotherapy and Oncology, 1986
- Placental alkaline phosphatase as a tumour marker in seminoma using the H17 E2 monoclonal antibody assayBritish Journal of Cancer, 1985
- Subsequent malignancies in patients irradiated for testicular tumoursThe British Journal of Radiology, 1984
- The implications of scrotal interference for the preservation of spermatogenesis in the management of testicular tumoursBritish Journal of Surgery, 1977
- SEMINOMA OF THE TESTIS: ANALYSIS OF TREATMENT SUCCESS AND FAILUREAmerican Journal of Roentgenology, 1968